Ftse Mib
34.478,84
0,05%
DAX
18.691,32
0,05%
S&P 500
5.320,03
0,25%
NASDAQ
16.927,39
0,75%
Bitcoin
67.947,01
-1,67%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. USOTC Arno Therapeutics Inc (CE) (ARNI) Arno Therapeutics Inc (CE) (ARNI) Notizie

ARNI

Arno Therapeutics (CE) (ARNI)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:ARNI
DataOraFonteTitoloSimboloCompagnia
03/01/201823:21Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:ARNIArno Therapeutics Inc (CE)
03/04/201712:01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ARNIArno Therapeutics Inc (CE)
28/03/201723:05Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:ARNIArno Therapeutics Inc (CE)
28/03/201723:00Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:ARNIArno Therapeutics Inc (CE)
09/01/201718:51Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:ARNIArno Therapeutics Inc (CE)
09/01/201718:50Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:ARNIArno Therapeutics Inc (CE)
03/01/201722:28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ARNIArno Therapeutics Inc (CE)
03/01/201722:27Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:ARNIArno Therapeutics Inc (CE)
18/11/201622:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:ARNIArno Therapeutics Inc (CE)
14/11/201622:14Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ARNIArno Therapeutics Inc (CE)
04/11/201621:42Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:ARNIArno Therapeutics Inc (CE)
04/11/201611:04Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ARNIArno Therapeutics Inc (CE)
12/10/201621:05Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:ARNIArno Therapeutics Inc (CE)
08/09/201622:03Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)USOTC:ARNIArno Therapeutics Inc (CE)
30/08/201621:10Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:ARNIArno Therapeutics Inc (CE)
16/08/201615:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ARNIArno Therapeutics Inc (CE)
16/08/201614:01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ARNIArno Therapeutics Inc (CE)
15/04/201616:53Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:ARNIArno Therapeutics Inc (CE)
01/04/201621:40Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:ARNIArno Therapeutics Inc (CE)
30/03/201622:06Edgar (US Regulatory)Annual Report (10-k)USOTC:ARNIArno Therapeutics Inc (CE)
24/03/201621:43Edgar (US Regulatory)Confidential Treatment Order (ct Order)USOTC:ARNIArno Therapeutics Inc (CE)
17/02/201522:30Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)USOTC:ARNIArno Therapeutics Inc (CE)
17/02/201522:05Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:ARNIArno Therapeutics Inc (CE)
18/07/201422:30GlobeNewswire Inc.Arno Therapeutics, Inc. Appoints Alexander Zukiwski, M.D. as Interim Chief Executive Officer and Mr. Lawrence Kenyon as Chief...USOTC:ARNIArno Therapeutics Inc (CE)
29/05/201422:30GlobeNewswire Inc.Arno Therapeutics to Present at the Jefferies 2014 Global Healthcare ConferenceUSOTC:ARNIArno Therapeutics Inc (CE)
15/05/201422:40GlobeNewswire Inc.Arno Therapeutics Reports First Quarter 2014 Financial and Business UpdateUSOTC:ARNIArno Therapeutics Inc (CE)
14/05/201423:00GlobeNewswire Inc.Arno Therapeutics to Outline Two Phase I Studies Evaluating Onapristone in Men's and Women's Cancers at 2014 ASCO Annual Meet...USOTC:ARNIArno Therapeutics Inc (CE)
05/05/201414:30GlobeNewswire Inc.Arno Therapeutics Announces Clinical Abstracts Accepted at 2014 ASCO Annual MeetingUSOTC:ARNIArno Therapeutics Inc (CE)
07/04/201416:42GlobeNewswire Inc.Arno Therapeutics Enrolls First Patient in a Phase I/II Trial Evaluating Onapristone in Men with Advanced Castration-Resistan...USOTC:ARNIArno Therapeutics Inc (CE)
01/04/201415:10GlobeNewswire Inc.Arno Therapeutics Reports 2013 Financial Results and Provides Update on Strategic and Operational MilestonesUSOTC:ARNIArno Therapeutics Inc (CE)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:ARNI

La tua Cronologia

BIT
UCG
Unicredit
BIT
ENEL
Enel
BIT
STMMI
ST Microelectronics
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
TIT
Telecom Italia
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENI
Eni
BIT
WBD
WeBuild
BIT
TITR
Telecom Italia
BIT
SRG
Snam
BIT
SPM
Saipem
BIT
RACE
Ferrari NV
BIT
TEN
Tenaris
BIT
BPE
Bper Banca
BIT
PRY
Prysmian
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network